Latest SUVRETTA CAPITAL MANAGEMENT, LLC Stock Portfolio
SUVRETTA CAPITAL MANAGEMENT, LLC Performance:
2024 Q3: 6.42%YTD: 15.49%2023: 16.5%
Performance for 2024 Q3 is 6.42%, and YTD is 15.49%, and 2023 is 16.5%.
About SUVRETTA CAPITAL MANAGEMENT, LLC and 13F Hedge Fund Stock Holdings
SUVRETTA CAPITAL MANAGEMENT, LLC is a hedge fund based in NEW YORK, NY. On 14-Jun-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $5.2 Billions. In it's latest 13F Holdings report, SUVRETTA CAPITAL MANAGEMENT, LLC reported an equity portfolio of $3.1 Billions as of 30 Sep, 2024.
The top stock holdings of SUVRETTA CAPITAL MANAGEMENT, LLC are , KURA, INSM. The fund has invested 8.3% of it's portfolio in BIOHAVEN LTD and 4.8% of portfolio in KURA ONCOLOGY INC.
The fund managers got completely rid off ELEVANCE HEALTH INC (ELV), SYSCO CORP (SYY) and FERGUSON PLC NEW (FERG) stocks. They significantly reduced their stock positions in ALNYLAM PHARMACEUTICALS INC (ALNY), ARCELLX INC (ACLX) and FULCRUM THERAPEUTICS INC (FULC). SUVRETTA CAPITAL MANAGEMENT, LLC opened new stock positions in STARBUCKS CORP (SBUX), FERGUSON ENTERPRISES INC and CAPITAL ONE FINL CORP (COF). The fund showed a lot of confidence in some stocks as they added substantially to DEXCOM INC (DXCM), BENITEC BIOPHARMA INC (BNTC) and JOHNSON & JOHNSON (JNJ).
The top stock holdings of SUVRETTA CAPITAL MANAGEMENT, LLC are , KURA, INSM. The fund has invested 8.3% of it's portfolio in BIOHAVEN LTD and 4.8% of portfolio in KURA ONCOLOGY INC.
The fund managers got completely rid off ELEVANCE HEALTH INC (ELV), SYSCO CORP (SYY) and FERGUSON PLC NEW (FERG) stocks. They significantly reduced their stock positions in ALNYLAM PHARMACEUTICALS INC (ALNY), ARCELLX INC (ACLX) and FULCRUM THERAPEUTICS INC (FULC). SUVRETTA CAPITAL MANAGEMENT, LLC opened new stock positions in STARBUCKS CORP (SBUX), FERGUSON ENTERPRISES INC and CAPITAL ONE FINL CORP (COF). The fund showed a lot of confidence in some stocks as they added substantially to DEXCOM INC (DXCM), BENITEC BIOPHARMA INC (BNTC) and JOHNSON & JOHNSON (JNJ).
SUVRETTA CAPITAL MANAGEMENT, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that SUVRETTA CAPITAL MANAGEMENT, LLC made a return of 6.42% in the last quarter. In trailing 12 months, it's portfolio return was 36.85%.
New Buys
| Ticker | $ Bought |
|---|---|
| starbucks corp | 53,649,600 |
| ferguson enterprises inc | 44,720,000 |
| capital one finl corp | 35,276,400 |
| crowdstrike hldgs inc | 34,260,800 |
| bioage labs inc | 30,264,000 |
| keurig dr pepper inc | 26,352,000 |
| las vegas sands corp | 24,370,100 |
| wynn resorts ltd | 12,752,000 |
New stocks bought by SUVRETTA CAPITAL MANAGEMENT, LLC
Additions
| Ticker | % Inc. |
|---|---|
| dexcom inc | 438 |
| benitec biopharma inc | 422 |
| johnson & johnson | 53.66 |
| pinterest inc | 50.24 |
| tesla inc | 43.68 |
| goldman sachs group inc | 38.95 |
| marinus pharmaceuticals inc | 32.82 |
| prokidney corp | 32.12 |
Additions to existing portfolio by SUVRETTA CAPITAL MANAGEMENT, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| alnylam pharmaceuticals inc | -63.26 |
| arcellx inc | -54.5 |
| fulcrum therapeutics inc | -53.45 |
| ultragenyx pharmaceutical in | -44.15 |
| insmed inc | -35.14 |
| arcus biosciences inc | -30.68 |
| sanofi | -16.99 |
| contineum therapeutics inc | -16.23 |
SUVRETTA CAPITAL MANAGEMENT, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| immatics n.v | -10,999,100 |
| sysco corp | -37,187,100 |
| chipotle mexican grill inc | -24,966,000 |
| ferguson plc new | -28,087,000 |
| tourmaline bio inc | -1,607,500 |
| spyre therapeutics inc | -2,522,860 |
| elevance health inc | -49,548,800 |
| mereo biopharma group plc | -270,000 |
SUVRETTA CAPITAL MANAGEMENT, LLC got rid off the above stocks
Sector Distribution
SUVRETTA CAPITAL MANAGEMENT, LLC has about 44.7% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 44.7 |
| Others | 21.6 |
| Technology | 9 |
| Consumer Cyclical | 8.6 |
| Communication Services | 7.2 |
| Financial Services | 3.2 |
| Consumer Defensive | 2.5 |
| Basic Materials | 1.9 |
| Industrials | 1.4 |
Market Cap. Distribution
SUVRETTA CAPITAL MANAGEMENT, LLC has about 44.4% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 23.4 |
| UNALLOCATED | 23.3 |
| MEGA-CAP | 21 |
| SMALL-CAP | 16.7 |
| MID-CAP | 8.7 |
| MICRO-CAP | 6.7 |
Stocks belong to which Index?
About 65.7% of the stocks held by SUVRETTA CAPITAL MANAGEMENT, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| S&P 500 | 35.9 |
| Others | 34.3 |
| RUSSELL 2000 | 29.8 |
SUVRETTA CAPITAL MANAGEMENT, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of SUVRETTA CAPITAL MANAGEMENT, LLC
SUVRETTA CAPITAL MANAGEMENT, LLC has 96 stocks in it's portfolio. About 36.5% of the portfolio is in top 10 stocks. PEPG proved to be the most loss making stock for the portfolio. ACLX was the most profitable stock for SUVRETTA CAPITAL MANAGEMENT, LLC last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| A | agilent technologies inc | 0.02 | 4,990 | 740,915 | unchanged | 0.00 | ||
| AAPL | apple inc | 2.51 | 336,147 | 78,322,200 | reduced | -7.49 | ||
| ABC | cencora inc | 0.09 | 12,488 | 2,810,800 | unchanged | 0.00 | ||
| ABEO | abeona therapeutics inc | 0.74 | 3,685,500 | 23,292,400 | unchanged | 0.00 | ||
| ABT | abbott labs | 0.12 | 33,520 | 3,821,620 | unchanged | 0.00 | ||
| ACLX | arcellx inc | 1.84 | 689,950 | 57,617,700 | reduced | -54.5 | ||
| AGLE | spyre therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALGN | align technology inc | 0.01 | 1,100 | 279,752 | unchanged | 0.00 | ||
| ALNY | alnylam pharmaceuticals inc | 0.12 | 13,824 | 3,802,020 | reduced | -63.26 | ||
| AMD | advanced micro devices inc | 1.82 | 346,575 | 56,866,000 | added | 0.17 | ||
| AMZN | amazon com inc | 2.10 | 352,069 | 65,601,000 | reduced | -1.18 | ||
| ARQT | arcutis biotherapeutics inc | 3.19 | 10,721,500 | 99,710,000 | added | 7.17 | ||
| AVTR | avantor inc | 0.06 | 71,850 | 1,858,760 | unchanged | 0.00 | ||
| BAX | baxter intl inc | 0.01 | 7,970 | 302,621 | unchanged | 0.00 | ||
| BIIB | biogen inc | 0.19 | 29,946 | 5,804,730 | new | |||
| BNDD | kraneshares trust | 0.25 | 230,000 | 7,824,600 | new | |||
| BNTC | benitec biopharma inc | 2.60 | 8,829,050 | 81,139,000 | added | 422 | ||
| BSX | boston scientific corp | 0.68 | 251,689 | 21,091,500 | unchanged | 0.00 | ||
| CI | the cigna group | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CMG | chipotle mexican grill inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||